-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Import duties and VAT / sales tax
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Performance Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
-
Monitoring and Evaluation
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- M&E Components of Grant Implementation
- Monitoring and Evaluation Components of Grant Making
- Overview
- Principal Recipient Start-Up
-
Health Product Management
- Compliance with the Global Fund requirements
- Distribution
- Inspection and Receipt
- International freight, transit requirements and use of INCOTERMS
- Inventory Management
- Overview - Health Product Management
- Pharmacovigilance
- Product Selection
- Quality monitoring of health products
- Quantification and Forecasting
- Rational use
- Risk Management for PSM of health products
-
Sourcing and regulatory aspects
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Global Health Procurement Center (GHPC)
- Guidance on donations of health products
- Health Procurement Architecture
- Local Procurement of health products
- Other Elements of the UNDP Procurement Architecture
- Procurement of non-pharmaceutical Health Products
- Procurement of Pharmaceutical Products
- Submission of GHPC CO Procurement Request Form
- Storage
- Supply Planning of Health Products
- UNDP Health PSM Roster
- Waste management
- Grant Reporting
-
Risk Management
- Introduction to Risk Management
- Overview
- Risk management in crisis settings
-
Risk Management in the Global Fund
- Additional Safeguard Policy
- Challenging Operating Environment (COE) Policy
- Global Fund Review of Risk Management During Grant Implementation
- Global Fund Risk Management Framework
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Risk Management Requirements for PRs
- Local Fund Agent
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Sub-Recipient Management
Local Procurement of health products
Procurement of health products is associated with very specific and unique risks for the organization. This includes, amongst many others, the risks around the quality of the health products that can pose an immediate risk to human life, and the risk of sub-standard health outcomes.
To mitigate these risks, UNDP’s OPG determined that the quality assurance review process for all health procurement should be centrally processed by the Global Health Procurement Center (GHPC) regardless of the funding source, and that all local procurement of health products is fully subject to corporate risk management procedures [1].
All procurement of health products that is financed through the Global Fund, where UNDP is either the PR or has signed a Financing Agreement (FA) with another PR, must be centrally processed by the Global Health Procurement Center (GHPC).
In “special circumstances”, UNDP COs that procure health products financed through the Global Fund may submit a request, supported by a detailed justification, to the UNDP GFPHST Senior Health PSM Advisor for authorization to source the health products locally. UNDP GFPHST will review such requests and, based on detailed risk assessment, may authorize local procurement. Such authorizations would be 1) exceptional, 2) for the specific list of health products and quantities, and 3) timebound. Any authorised local procurement must adhere to UNDP’s procurement procedures and UNDP’s QA policy for health products.
COs that implement procurement of health products using funds outside of Global Fund grants are strongly encouraged to use the GHPC to mitigate against the risks that are unique to procuring health products and to ensure full compliance with the UNDP QA Policy. COs that choose to manage procurement of health products outside of the GHPC, must develop a procurement sourcing and risk management strategy in consultation and agreement with the relevant Regional Bureau, BPPS (HHG/GFPHST), and BMS (health procurement team), and must still engage the services of the GHPC QAS team[1]. The strategy should determine how the best value for money and lowest risk is achieved using either CO-led procurement or the specialized services of the BPPS/BMS Global Health Procurement Center (GHPC) while taking into account the relevant project aspect.
As mentioned in the Risk Management section of this manual “Non-compliance with the UNDP procurement rules and regulations and quality assurance policy requirements could create substantial liabilities for UNDP, which are highlighted in the Potential Liabilities Related to Health Procurement document here.”
[1] OPG Decisions, 19 November 2017.
Additional guidance to support this area of work are also available through resources listed below:
Loading resources
